Literature DB >> 17565272

Mineral metabolism and aging: the fibroblast growth factor 23 enigma.

Beate Lanske1, M Shawkat Razzaque.   

Abstract

PURPOSE OF REVIEW: The regulation of phosphate homeostasis was thought to be passively mediated by the calciotrophic hormones parathyroid hormone and 1,25(OH)2D3. This article summarizes the emerging trends that show an active regulation of phosphate homeostasis by fibroblast growth factor 23 (FGF-23) - a process fairly independent of calcium homeostasis - and how altered mineral ion metabolism may affect the aging process. RECENT
FINDINGS: A major breakthrough in FGF-23 biology has been achieved by the demonstration of strikingly similar physical/biochemical phenotypes of Fgf-23(-/-) and klotho hypomorph mice, which eventually led to the identification of klotho as a cofactor in FGF-23 and its receptor interactions. Furthermore, FGF-23 has emerged as a counter regulator of the renal 1alpha(OH)ase and sodium-phosphate cotransporter activities to modulate phosphate homeostasis. Finally, studies point towards a role of dentine matrix protein 1 in affecting phosphate homeostasis, in coordination with FGF-23.
SUMMARY: Recent mouse genetic studies have broadened our understanding of biochemical/molecular pathways involved in phosphate homeostasis, and linked FGF-23 to such regulation. Understanding the molecular interactions of essential calcium and phosphate regulators will enhance our knowledge of the coordinated regulation of mineral ion metabolism, and will help to redefine the molecular pathology of age-associated lesions accompanied by abnormal mineral ion metabolism such as vascular calcifications and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565272      PMCID: PMC2901548          DOI: 10.1097/MNH.0b013e3281c55eca

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  72 in total

1.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.

Authors:  B Dawson-Hughes; S S Harris; E A Krall; G E Dallal
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

2.  Soft tissue calcification in pediatric patients with end-stage renal disease.

Authors:  D S Milliner; A R Zinsmeister; E Lieberman; B Landing
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

Review 3.  Fibroblast growth factor 23: a phosphatonin regulating phosphate homeostasis?

Authors:  Colin R Dunstan; Hong Zhou; Markus J Seibel
Journal:  Endocrinology       Date:  2004-07       Impact factor: 4.736

4.  Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis.

Authors:  D J Goldsmith; A Covic; P A Sambrook; P Ackrill
Journal:  Nephron       Date:  1997       Impact factor: 2.847

5.  Gains in bone mineral density with resolution of vitamin D intoxication.

Authors:  J S Adams; G Lee
Journal:  Ann Intern Med       Date:  1997-08-01       Impact factor: 25.391

6.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.

Authors:  Orit Topaz; Daniel L Shurman; Reuven Bergman; Margarita Indelman; Paulina Ratajczak; Mordechai Mizrachi; Ziad Khamaysi; Doron Behar; Dan Petronius; Vered Friedman; Israel Zelikovic; Sharon Raimer; Arieh Metzker; Gabriele Richard; Eli Sprecher
Journal:  Nat Genet       Date:  2004-05-09       Impact factor: 38.330

7.  In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions.

Authors:  Philippe H Tartaix; Marie Doulaverakis; Anne George; Larry W Fisher; William T Butler; Chunlin Qin; Erdjan Salih; Melin Tan; Yukiji Fujimoto; Lyudmila Spevak; Adele L Boskey
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

8.  Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

Authors:  Xiuying Bai; Dengshun Miao; Jiarong Li; David Goltzman; Andrew C Karaplis
Journal:  Endocrinology       Date:  2004-07-29       Impact factor: 4.736

9.  Annual injection of vitamin D and fractures of aged bones.

Authors:  R J Heikinheimo; J A Inkovaara; E J Harju; M V Haavisto; R H Kaarela; J M Kataja; A M Kokko; L A Kolho; S A Rajala
Journal:  Calcif Tissue Int       Date:  1992-08       Impact factor: 4.333

10.  Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

Authors:  Tobias Larsson; Richard Marsell; Ernestina Schipani; Claes Ohlsson; Osten Ljunggren; Harriet S Tenenhouse; Harald Jüppner; Kenneth B Jonsson
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more
  15 in total

1.  Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.

Authors:  Mohammed S Razzaque
Journal:  Expert Opin Ther Pat       Date:  2010-07       Impact factor: 6.674

2.  Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?

Authors:  M Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2007-10-31       Impact factor: 5.992

3.  Checkpoint kinase Chk2 controls renal Cyp27b1 expression, calcitriol formation, and calcium-phosphate metabolism.

Authors:  Hajar Fahkri; Bingbing Zhang; Abul Fajol; Nati Hernando; Bernat Elvira; Julia G Mannheim; Bernd J Pichler; Christoph Daniel; Kerstin Amann; Atsushi Hirao; Jillian Haight; Tak W Mak; Florian Lang; Michael Föller
Journal:  Pflugers Arch       Date:  2014-10-17       Impact factor: 3.657

Review 4.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 5.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Bonekey Rep       Date:  2015-06-03

6.  FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.

Authors:  Quan Yuan; Tadatoshi Sato; Michael Densmore; Hiroaki Saito; Christiane Schüler; Reinhold G Erben; Beate Lanske
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

Review 7.  The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.

Authors:  Mohammed S Razzaque; Beate Lanske
Journal:  J Endocrinol       Date:  2007-07       Impact factor: 4.286

Review 8.  Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?

Authors:  Fahad Memon; Mohga El-Abbadi; Teruyo Nakatani; Takashi Taguchi; Beate Lanske; M Shawkat Razzaque
Journal:  Kidney Int       Date:  2008-06-04       Impact factor: 10.612

9.  In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.

Authors:  Teruyo Nakatani; Bara Sarraj; Mutsuko Ohnishi; Michael J Densmore; Takashi Taguchi; Regina Goetz; Moosa Mohammadi; Beate Lanske; M Shawkat Razzaque
Journal:  FASEB J       Date:  2008-10-03       Impact factor: 5.191

10.  Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23.

Authors:  S DeLuca; D Sitara; K Kang; R Marsell; K Jonsson; T Taguchi; R G Erben; M S Razzaque; B Lanske
Journal:  J Pathol       Date:  2008-11       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.